Science

Monsanto lose $290 million glyphosate court case

Monsanto lose $290 million glyphosate court case

The active chemical in Roundup - glyphosate - has been classified as "probably carcinogenic" by the World Health Organisation but is still approved for use in Australia and the US. However, he is one of many allegedly suffering because of Roundup weedkiller. "It would be nice if we could tell people why they get it, but we can't".

Shares in Bayer AG (BAYRY) plunged more than 10% in early morning trade on Monday after Monsanto lost a case and looked set for more legal trouble in the near future.

Bayer said it will appeal and US jury awards against companies are often overturned or reduced.

"It is the most widely used and most widely studied herbicide in the world", Partridge said.

Having closed the Monsanto takeover, Bayer is only awaiting some final antitrust-related asset sales before folding it into its own organization. It has been good for the environment and good for farmers, and it'll be needed as the global population expands by billions in the coming decades, Perrella said. "That would use extra diesel, which is bad for the soil and the environment".

"Through the use of glyphosate, farmers are able to practise minimum tillage - protecting soil structure and nutrients and ultimately increasing the storage of soil carbon", she said. At the same time, there's been growing consumer distrust of crop chemicals and GMOs, helping to drive a surge in demand for organic food.

Johnson's case is the first of its kind to proceed to trial because of his terminal diagnosis.




Monsanto has long argued there is no proof glyphosate is carcinogenic, citing a report conducted by the Environmental Protection Agency's (EPA) Assessment Review Committee that says the chemical is "not likely to be carcinogenic to humans" as well as "hundreds of studies" conducted around the world that show glyphosate's safety.

Tobias said Monsanto's promised appeal could result in the charges being reduced - but said the company "might want to consider settling now, depending on its calculus of the risk that it might lose on appeal and the adverse publicity that might arise from losing or from continuing to contest the verdict".

Anti-GMO onlookers rejoiced after the verdict.

Despite not being the first to sue Monsanto for this reason, his case is the first to actually make it to trial. The Brazilian Soy Producers Association has promptly appealed.

"We think the risk of withdrawal is extremely low, but if it materialized it would be a major blow to the transaction value paid for the company", said Berenberg's Campbell.

"Ultimately, GMO haters have been spectacularly unsuccessful - as much as they hate it and with the passion they hate it, penetration of GMOs keeps increasing every year".